Trinity Biotech plc
Symbol: TRIB (NASDAQ)
1.11
▼ (-3.07%) -0.035
Company Description:
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Key Stats
- Today's Open: $1.19
- Today's High: $1.195
- Today's Low: $1.105
- Today's Volume: 88.03K
- Yesterday Close: $1.14
- Yesterday High: $1.1899
- Yesterday Low: $1.125
- Yesterday Volume: 68.43K
- Last Min Volume: 20
- Last Min High: $1.105
- Last Min Low: $1.105
- Last Min VWAP: $1.105
Company Profile
- Name: Trinity Biotech plc
- Website: https://www.trinitybiotech.com
- Listed Date: 1992-10-21
- Location: ,
- Market Status: Active
- CIK Number: 0000888721
- SIC Code:
- SIC description:
- Market Cap: $4.25M
- Round Lot: 100
- Outstanding Shares: 3.73M
- Asset Type: ADRC
RECENT FILINGS FOR TRIB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 6-K | View |
| 2025-09-02 | 6-K | View |
| 2025-08-20 | 6-K | View |
| 2025-08-15 | 6-K | View |
| 2025-08-12 | 6-K | View |
| 2025-08-08 | 6-K | View |
| 2025-07-24 | 6-K | View |
| 2025-07-01 | 6-K | View |
| 2025-06-24 | 6-K | View |
| 2025-05-16 | 20-F | View |
| 2025-05-15 | 6-K | View |
| 2025-04-30 | NT 20-F | View |
| 2025-04-04 | 6-K | View |
| 2025-03-31 | 424B3 | View |
| 2025-03-28 | EFFECT | View |
| 2025-03-26 | CORRESP | View |
| 2025-03-26 | UPLOAD | View |
| 2025-03-25 | SCHEDULE 13D/A | View |
| 2025-03-21 | F-3 | View |
| 2025-03-14 | 6-K | View |
Latest News on TRIB